1-6 of 6
Priyangi A. Malaviarachchi
Close
Sort by
Journal Articles

Myeloma-Derived Exosomes and Soluble Factors Suppress Natural Killer Cell Function

Tarun K. Garg, PhD, Jessica I Gann, Priyangi A Malaviarachchi, BS, Kate Stone, BS, Veronica Macleod, Amy D Greenway, Nisreen S Akel, Ricky D Edmondson, PhD, Faith E Davies, MD, Joshua Epstein, DSc, Gareth J Morgan, MD PhD, Frits van Rhee, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2066.
https://doi.org/10.1182/blood.V128.22.2066.2066
Published: 2016
Journal Articles

Stem Cell-like Characteristics of MM Plasma Cells Vary By ROS Levels: Implications for Targeted Therapy

Priyangi A Malaviarachchi, BS, Donald E Turner, BS, Caleb K. Stein, MS, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD, Sarah K. Johnson, PhD
Journal: Blood
Blood (2015) 126 (23): 1820.
https://doi.org/10.1182/blood.V126.23.1820.1820
Published: 2015
Journal Articles

CREB Deficiency: A Potential Critical Factor for Selective GM-CSF Hypersensitivity in Juvenile Myelomonocytic Leukemia.

Y. Lucy Liu, MD, PhD, Priyangi A Malaviarachchi, BS, Shelly Y. Lensing, MS, Robert P. Castleberry, MD, Peter Dean Emanuel, MD
Journal: Blood
Blood (2009) 114 (22): 2604.
https://doi.org/10.1182/blood.V114.22.2604.2604
Published: 2009
Journal Articles

Activation and Expansion of Natural Killer (NK) Cells with Potent Cytotoxicity for Multiple Myeloma

Jumei Shi, MD, PhD, Susann Szmania, BS, Guido Tricot, MD, PhD, Tarun K. Garg, PhD, Priyangi A Malaviarachchi, BS, Amberly Moreno-Bost, BS, Katie Stone, BS, Fenghuang Zhan, MD, PhD, Dario Campana, MD, PhD, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2758.
https://doi.org/10.1182/blood.V112.11.2758.2758
Published: 2008
Journal Articles

Bortezomib down-regulates the cell-surface expression of HLA class I and enhances natural killer cell–mediated lysis of myeloma

Jumei Shi, Guido J. Tricot, Tarun K. Garg, Priyangi A. Malaviarachchi, Susann M. Szmania, Rachel E. Kellum, Brian Storrie, Arend Mulder, John D. Shaughnessy, Jr, Bart Barlogie, Frits van Rhee
Journal: Blood
Blood (2008) 111 (3): 1309–1317.
https://doi.org/10.1182/blood-2007-03-078535
Published: 2008
Includes: Supplemental data
Journal Articles

A Novel Mechanism of Action of Bortezomib: Proteasome Inhibition Down-Regulates HLA-Class I on Myeloma and Enhances NK Cell-Mediated Lysis.

Jumei Shi, MD, PhD, Guido J. Tricot, MD, PhD, Priyangi A. Malaviarachchi, Tarun K. Garg, PhD, Susann M. Szmania, Arend Mulder, PhD, John D. Shaughnessy, PhD, Bart Barlogie, MD, PhD, Frits van Rhee, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1525.
https://doi.org/10.1182/blood.V110.11.1525.1525
Published: 2007